ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to ...

Supplements are being recalled because they contain prescription diabetes drugs that could have fatal side effects.

NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...

On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering ...

HPH-15, a compound developed by Kumamoto University, reduces blood glucose and fat accumulation more effectively than ...

Biomea also drilled down into subgroups of patients with mild age-related diabetes and severe insulin-deficient diabetes, ...

Related Stories Revolutionary obesity and diabetes treatment burns energy and reduces appetite without side effects ...

Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access the drugs.

Discover recent studies have highlighted the potential of sodium-glucose cotransporter 2 inhibitors, especially ertugliflozin ...

The National Health Facility Survey 2023 carried out by the National Bureau of Statistics said the national percentage of facilities providing diabetes services was 13.9 per cent, while that of ...

marking a significant leap in diabetes treatment ... Eating Dark Chocolate Linked With Reduced Risk of Type 2 Diabetes Dec. 4, 2024 — Consuming dark, but not milk, chocolate may be associated ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.